Articles by J.M. Liddell, PhD - BioPharm International

home: :

Articles by J.M. Liddell, PhD

john.liddell@avecia.com

J.M.Liddell, PhD, is head of process science at Avecia Biologics Ltd.

Production Strategies for Antibody Fragment Therapeutics
June 2, 2009
By: J.M. Liddell, PhD

Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.